Choose Your Location
|
![]() |
TUSTIN, Calif. (Map) -
The company is releasing the new GOODNAK formulations in partnership with JJB, the subsidiary of AMDL's Chinese subsidiary Jade Pharmaceutical Inc. (JPI). Scheduled to be released next month, the GOODNAK product includes Human Placental Histosolution, and effective and key component in anti-aging products which has been shown to give skin a youthful look by increasing cell renewal and smoothening fine lines.
JJB has applied to Chinese regulatory authorities for product approval and
anticipates sanction this month. Based on the general market information, the
proposed pricing for the new GOODNAK products is anticipated to be
approximately (U.S.)
About AMDL:
AMDL, Inc. is a global specialty pharmaceutical company. The Company is
headquartered in
About Jade Pharmaceutical:
JPI has access to the fastest growing pharmaceutical and consumer market
in the world:
IR Contact: Mr.
Direct: 949.707.5365 Voicemail: 714.505.4460
|
|


